FREE STANDARD SHIPPING ON ORDERS $250+

CJC 1295 (no dac)

From $62.40

Shop

CJC 1295 (no dac) · Research brief

CJC-1295 No DAC & Ipamorelin Research Journaling Template

58 WORDS

Short answer

A research journaling template for CJC-1295 no DAC and ipamorelin is a fixed set of record fields — compound identity, lot number, certificate of analysis reference, receipt date and condition, storage conditions, concentration expressed in milligrams per milliliter, observations, deviations, and a dated signature — that ties every vial in your inventory back to a verifiable paper trail.

CJC-1295 No DAC & Ipamorelin Research Journaling Template

A research journaling template for CJC-1295 no DAC and ipamorelin is a fixed set of record fields — compound identity, lot number, certificate of analysis reference, receipt date and condition, storage conditions, concentration expressed in milligrams per milliliter, observations, deviations, and a dated signature — that ties every vial in your inventory back to a verifiable paper trail. It is a documentation tool, not a protocol. Real Peptides does not publish dosing, administration, or preparation guidance, because these are research-use-only compounds. What a template can legitimately do is make every unit you stock traceable to the batch it came from, and make that traceability survive a question asked six months later.

This matters to a wholesale buyer differently than it matters to a bench researcher. If you are stocking a catalog, the log is the thing that connects a purchase order, a lab result, and a physical vial on a shelf. Below is the field structure, the reasoning behind each field, and — just as important — what a supplier has to give you before the template can be filled in at all.

Why documentation is a purchasing problem first

Buyers usually think about record-keeping as something that happens after the order arrives. In practice, the quality of your records is decided at the point of purchase. A log entry can only be as specific as the information printed on the vial and published by the supplier. If a shipment arrives with no lot marking, or with a certificate of analysis that cannot be matched to the batch in hand, the template has blank fields on day one — and blank fields are the ones that cause problems.

There are three moments where this shows up. The first is an internal question: two vials of the same compound are on the shelf, one behaves differently in handling, and nobody can tell which batch each came from. The second is an external question: a buyer, an auditor, or a business partner asks where a specific unit originated. The third is the unpleasant one — a supplier issue that requires you to identify and segregate everything from a particular batch. A complete log makes all three a lookup. An incomplete log makes them an investigation.

Record-keeping obligations vary by business type, jurisdiction, and the licenses you hold, and this article is informational rather than legal advice. What records you are required to retain, for how long, and in what form are questions for your attorney and your state board — not questions a supplier or a blog post should answer for you. The template described here is a practical baseline, not a compliance certification.

Why these two compounds are usually documented together

CJC-1295 no DAC is a modified growth hormone-releasing hormone analog; without the drug affinity complex modification, it has a substantially shorter circulating profile than the DAC version. Ipamorelin belongs to a different class — a selective growth hormone secretagogue that acts at the ghrelin receptor. Because the two act on distinct pathways within growth hormone signaling research, published literature frequently discusses them alongside each other, and laboratories commonly hold both. Research in this area is ongoing and findings are preliminary; nothing here should be read as a claim about outcomes in humans.

For documentation purposes, the practical consequence is simple: two different compounds, two different lots, two different certificates of analysis, and two separate log threads that need to stay separate. Combining them into a single entry is the most common structural error in a homemade template. Each compound gets its own record line, always, even when they were received in the same shipment on the same invoice.

The field structure of a usable log

The table below is the minimum field set. Everything in it is either printed on the vial, stated on the certificate of analysis, recorded at intake, or observed in the lab. Nothing in it describes preparation or administration.

Field What to record Why it exists
Entry ID and date Sequential identifier plus the date the entry was written Establishes a contemporaneous record rather than a reconstruction
Compound identity Name exactly as labeled, including the no DAC designation Prevents CJC-1295 no DAC from being conflated with the DAC form
Vial content as labeled Milligrams per vial as printed The anchor for any later concentration figure
Lot or batch number Transcribed exactly, including leading zeros The single field everything else hangs from
COA reference Where the certificate lives, purity figure, and which assays it covers Converts a marketing claim into a checkable document
Supplier and order reference Supplier name, invoice or order number, ship date Links the physical unit to the purchasing record
Receipt date and condition Date received, packaging condition, cold-chain state on arrival Documents the handoff point where responsibility transfers
Storage location and conditions Unit, shelf, temperature range, light exposure Supports any later question about handling history
Concentration Milligrams per milliliter, as a stated figure The reproducibility anchor for lab records
Purpose or study reference Internal project or reference number Ties the vial to a defined body of work
Observations Visual appearance, solubility behavior, anything anomalous The actual research content of the entry
Deviations and incidents Temperature excursions, damaged packaging, discrepancies Exceptions are worth more than routine entries
Reconciliation and disposition Units remaining, transfers, disposal record Closes the loop so the count on paper matches the shelf
Initials Of the person writing the entry Accountability, and the difference between a log and a notebook

Keep the template in a format that resists silent editing. A bound notebook with struck-through corrections, or an electronic system with version history, both work. A spreadsheet that anyone can overwrite without a trail does not — not because someone will falsify it, but because you lose the ability to prove nobody did.

The fields people skip, and what it costs

Lot number is the field that gets abbreviated, paraphrased, or left for later. It should be transcribed character for character at intake, before the vial is put away, and cross-checked against the shipping documentation. Everything downstream depends on it.

COA reference is the second. Recording that a certificate exists is not the same as recording where it is, what purity it states, and which assays it covers. A certificate that reports only purity is a narrower document than one that reports purity alongside identity confirmation, moisture, residual solvents, and microbial and endotoxin testing. Write down which panel you actually received, because "tested" is not a specification.

Receipt condition is the third. It takes fifteen seconds and it is the only record that distinguishes a problem introduced in transit from a problem introduced in your own storage. If packaging arrived compromised, that note is the most valuable line in the entire log.

Finally, deviations. Most logs record only what went as planned, which makes them nearly useless during a real inquiry. The excursion, the discrepancy, the vial that looked wrong — those are the entries someone will eventually read.

Where the record stops

Concentration in milligrams per milliliter is the ceiling for what belongs in a template like this, and it is worth being explicit about why. Recording that a solution is at a given mg/mL is a reproducibility fact about material in a lab. Anything beyond that figure — volumes, unit measurements, preparation sequences, frequency, or anything resembling a schedule — crosses out of documentation and into protocol, and Real Peptides does not provide that guidance in any form. These compounds are sold for laboratory research use only and are not FDA-approved drugs, not for human or veterinary consumption, and not for clinical or household use.

If you are searching for a journaling template because you want the preparation steps embedded in it, the honest answer is that no reputable supplier will supply them. What a supplier should give you instead is enough verified information about the material — identity, purity, batch, testing scope — that your own qualified personnel can document their work properly.

What a supplier has to provide for any of this to work

A template is only as good as the inputs. Before you commit to a wholesale relationship, check whether the supplier makes these possible.

Certificates of analysis should be publicly viewable and matched to batch, not emailed on request, not offered as a paid add-on, and not presented as a single generic document reused across every lot. If you cannot look up the result yourself, your log entry records a claim rather than a verification.

Testing scope should be stated, not implied. "Third-party tested" without a named panel tells you nothing you can write down. Purity should be reported with the method used, and the assay list should be visible before you order.

Pricing should be visible to qualified buyers without a negotiation ritual. Programs built around quote-only pricing and undisclosed tier structures make it difficult to reconcile invoices against inventory records, and they make cost comparison across suppliers a guessing exercise. Margins and minimums vary widely by category and volume across this industry; what should not vary is whether you can see the terms before you commit.

Fulfillment and labeling matter too. Lot markings on the vial, not just the outer packaging, keep records intact after the box is discarded.

What Real Peptides does differently

Real Peptides tests to 99%+ HPLC purity and runs a seven-panel batch test on production lots. Certificates of analysis are publicly verifiable — a prospective or current partner can look up the lab results directly rather than requesting them, which means the COA field in your log points to something an outside party can independently confirm. Fulfillment is handled in the US, with orders shipping in five to seven days.

The Wholesale Partner Program uses a three-step application: submit the application with your business details, complete verification, and receive partner pricing access. Pricing tiers are disclosed to approved partners rather than negotiated case by case.

If you operate a med spa, clinic, telehealth business, or reseller brand and you are building out documentation practices alongside your catalog, the Wholesale Partner Program application is the next step — it takes business information and verification, and approved partners get access to tiered pricing and the full batch documentation behind every lot they stock.

For the compounds discussed here, the product pages for CJC-1295 No DAC 10mg and Ipamorelin 10mg list the batch documentation you would reference in a log entry, Tesamorelin 10mg covers an adjacent line of growth hormone-releasing research, and the broader Growth Factor & Tissue Signaling Research collection groups the compounds most often documented together.

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

It is a fixed set of documentation fields — compound identity, lot number, COA reference, receipt date and condition, storage conditions, concentration in mg/mL, observations, deviations, and a dated signature. It records what material you hold and where it came from. It is not a protocol and contains no preparation guidance.
No. These are research-use-only compounds, so Real Peptides does not publish dosing, administration, or preparation guidance in any form. The useful framework for documentation is concentration expressed as milligrams per milliliter, which is a reproducibility fact about laboratory material rather than a protocol instruction.
They are different compounds acting on different pathways, arriving under different lot numbers with different certificates of analysis. Combining them into one entry breaks traceability the moment a batch-specific question arises. Log each compound separately, even when both arrived on the same invoice and the same day.
Transcribe the lot or batch number character for character, including leading zeros, before the vial is stored. Cross-check it against the shipping documentation and the certificate of analysis. Also record receipt date and the condition of packaging on arrival, which distinguishes transit issues from storage issues later.
Match the lot number on the vial to the lot number on the certificate, then confirm the purity figure, the testing method, and which assays the panel covers. Real Peptides publishes verifiable COAs, so the reference in your log points to a document an outside party can independently check.
That depends on your business type, your licenses, and your jurisdiction, and this is informational rather than legal advice. Retention requirements, formats, and timeframes are questions for your attorney and your state board. The template described here is a practical operational baseline, not a compliance determination.
It is a three-step process: submit the application with your business details, complete verification, then receive access to partner pricing. Approved partners see disclosed tier pricing rather than negotiating case by case, and can reference publicly verifiable batch documentation for every lot they stock.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA

Shop Now